Neurogene (NGNE) Short Interest Ratio & Short Volume → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free NGNE Stock Alerts $29.96 +0.09 (+0.30%) (As of 04/26/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Neurogene Short Interest DataCurrent Short Volume988,100 sharesPrevious Short Volume906,000 sharesChange Vs. Previous Month+9.06%Dollar Volume Sold Short$36.98 millionShort Interest Ratio / Days to Cover7.1Last Record DateApril 15, 2024Outstanding Shares12,853,000 sharesFloat Size11,510,000 sharesShort Percent of Float8.58%Today's Trading Volume47,839 sharesAverage Trading Volume125,821 sharesToday's Volume Vs. Average38% Short Selling Neurogene ? Sign up to receive the latest short interest report for Neurogene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNGNE Short Interest Over TimeNGNE Days to Cover Over TimeNGNE Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Neurogene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024988,100 shares $36.98 million +9.1%8.6%7.1 $37.43 3/31/2024906,000 shares $46.12 million +130.4%7.9%6.7 $50.90 3/15/2024393,200 shares $14.76 million +50.8%3.4%3.4 $37.53 2/29/2024260,700 shares $8.10 million +68.2%2.3%3.4 $31.07 2/15/2024155,000 shares $4.65 million +295.4%1.3%2.4 $30.00 1/31/202439,200 shares $1.18 million No Change0.4%0.8 $30.16 NGNE Short Interest - Frequently Asked Questions What is Neurogene's current short interest? Short interest is the volume of Neurogene shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 988,100 shares of NGNE short. 8.58% of Neurogene's shares are currently sold short. Learn More on Neurogene's current short interest. What is a good short interest ratio for Neurogene? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NGNE shares currently have a short interest ratio of 7.0. Learn More on Neurogene's short interest ratio. What is a good short interest percentage for Neurogene? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.58% of Neurogene's floating shares are currently sold short. Is Neurogene's short interest increasing or decreasing? Neurogene saw a increase in short interest in April. As of April 15th, there was short interest totaling 988,100 shares, an increase of 9.1% from the previous total of 906,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Neurogene's float size? Neurogene currently has issued a total of 12,850,000 shares. Some of Neurogene's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Neurogene currently has a public float of 11,510,000 shares. How does Neurogene's short interest compare to its competitors? 8.58% of Neurogene's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Neurogene: Travere Therapeutics, Inc. (15.50%), Theravance Biopharma, Inc. (14.72%), Oculis Holding AG (0.13%), KalVista Pharmaceuticals, Inc. (13.79%), Larimar Therapeutics, Inc. (5.69%), Fulcrum Therapeutics, Inc. (4.07%), Lexicon Pharmaceuticals, Inc. (8.17%), Mersana Therapeutics, Inc. (8.72%), Biomea Fusion, Inc. (49.86%), Corbus Pharmaceuticals Holdings, Inc. (6.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Neurogene stock? Short selling NGNE is an investing strategy that aims to generate trading profit from Neurogene as its price is falling. NGNE shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Neurogene? A short squeeze for Neurogene occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NGNE, which in turn drives the price of the stock up even further. How often is Neurogene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NGNE, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: TVTX Short Interest Data TBPH Short Interest Data OCS Short Interest Data KALV Short Interest Data LRMR Short Interest Data FULC Short Interest Data LXRX Short Interest Data MRSN Short Interest Data BMEA Short Interest Data CRBP Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NGNE) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press